Around 25,000 people die in the European Union each year from infections resistant to antibiotics. Third-generation cephalosporins are often useless against common bacteria like Escherichia coli, and fluoroquinolones are no longer the treatment of choice for gonorrhoea because resistance has become widespread. Here, you can find news stories and articles about the issue.
The chief executive of a national charity has welcomed a commitment by G20 health ministers to tackle antibiotic usage and begin implementing national action plans by the end of 2018.
Researchers in the United States use peptide from Komodo dragon to enhance wound healing in mice.
Source: Shutterstock.com The researchers behind the technology are currently focusing on using it to help individuals in intensive care with suspected pneumonia
The British Society of Antimicrobial Chemotherapy (BSAC) has, for the first time in its 45-year history, appointed a pharmacist to be its president.
Fluoroquinolones for treating tuberculosisSubscription
Tuberculosis (TB) remains a significant global health and socioeconomic challenge. The duration of current anti-TB therapies, the adverse effects of certain anti-TB drugs and the growing problem of drug-resistant TB on an international scale mean that it is imperative for new, effective and safe treatment regimens to be developed. Fluoroquinolones are a class of drugs that have been used in the treatment of TB for several decades. This article provides an overview of the current treatment ...
There are around 12,000 cases of Clostridium difficile infection (CDI) each year in the UK and during 1999 to 2007, deaths from CDI peaked at around 4,000 per year. This article summarises diagnosis and management, as well as the current therapeutic options for CDI, including faecal microbiota transplant.
As antibiotic resistance continues to threaten the treatment of various infections, researchers are looking for new ways to supplement and in some cases replace failing antimicrobial drugs.
Healthcare professionals should be aware of the principles of antimicrobial treatment and the need to reduce inappropriate prescribing to retain the effectiveness of drugs currently available.
Pharmacist independent prescribers can make a significant contribution to antimicrobial stewardshipSubscription
Karen Hodson, member of the Welsh Pharmacy Board, and colleagues discuss their experiences of how pharmacist prescribers can help in antimicrobial stewardship.
Over the past decade, infections caused by multidrug-resistant Gram-negative organisms have increased. The limited availability in treatment options for these infections prompted both the UK to create a five-year antimicrobial resistance strategic plan to stimulate the development of new antibiotics, and the Infectious Diseases Society of America to call for ten new antimicrobial agents to be developed by 2020. Ceftazidime-avibactam is a combination of a third-generation ...
Evidence is emerging that biocides and heavy metals all contribute to the growing problem of antimicrobial resistance.
As almost everyone in the business of caring for the health of humans and animals is acutely aware, on our current trajectory, it is estimated that antimicrobial resistance (AMR) will cause 10 million deaths annually by 2050, with many arising from simple infections following routine operations. This is why the UK government has placed antimicrobial resistance at the top of its risk register alongside terrorism and pandemic influenza.